Opening Kakao Healthcare Pasta Curriculum in Civil Service Training Program...Handok Donates Blood Donation Card on World Rare Disease Day
Feb 27, 2025
|
Kakao Healthcare and Korea's Jeongyeon Suwon signed a business agreement to support smart healthcare education.
Choi Ho-taek, director of the Korea Institute of Medicine (Professor of Public Administration at Baejae University), Yoon Kyung-joon (Professor of Global Business at Baejae University), Lee Young-hee, CEO of Kakao Healthcare, and Hong Heon-pyo, head of the external cooperation office, attended the signing ceremony held at Kakao Healthcare headquarters in Seongnam, Gyeonggi Province on the 26th. The two sides agreed to cooperate with each other in establishing a public-private cooperation model in which local governments can take the lead in managing chronic diseases smartly. The goal is to contribute to resolving the medical imbalance between regions by developing chronic disease management programs for local residents using smart technologies such as artificial intelligence (AI), big data, and mobile.
With this agreement, Kakao Healthcare's blood sugar management solution pasta (PASTA) training course will be opened in the public official training program operated by Korea's Jeongyeon Suwon. Civil service trainees will take blood sugar management education and experience smart healthcare using AI and big data at the same time.
|
On the occasion of World Rare Disease Day, Korea-Germany donated 450 blood donation cards to the Korea Blood Cancer Association. Blood donation cards delivered from Handok Tower in Yeoksam-dong, Seoul on the 26th are used for patients with rare diseases and blood cancer who need blood transfusions.
The Love Blood Donation Campaign is a volunteer activity involving executives and employees that Korea and Germany have been carrying out since 2007. Since 2015, the blood donation campaign for love has been held on February 28th 'World Rare Disease Day' and blood donation cards have been donated for patients with rare diseases and blood cancer who need blood transfusions.
Meanwhile, in order to overcome rare diseases, Handok is introducing innovative drugs in Korea one after another in areas where there is unmet demand and has provided not only treatments but also special medical foods. Major rare disease treatments include Fabry disease treatment Galapold, paroxysmal night hemoglobinuria (PNH) treatment Empabelli, chronic immune thrombocytopenia (ITP), and thrombocytopenia treatment for patients with chronic liver disease scheduled for the procedure, and systemic severe work history treatment Vivgart.
|
Guangdong Pharmaceutical conducted a 'Fair Trade Compliance Campaign'. Employees participating in the campaign held placards and pickets at the entrance of the headquarters with messages such as 「Fair Trade Culture Together」 and 「Fair Trade Creating Trust」, and strengthened their will to practice by announcing the importance of compliance with fair trade.
Guangdong Pharmaceutical further strengthened its ethical management by officially introducing the 「Fair Trade Compliance Program」 in January. Through this, ▲ reflection and implementation of business plans ▲ selection of self-compliance managers and formation of separate organizations in charge ▲ operation of internal management committees is systematically implemented. In addition, it has maintained the certification of the Anti-Corruption Management System (ISO 37001) and the Compliance Management System (ISO 37301) and has practiced ethical management that meets international standards.
A representative from Kwangdong Pharmaceutical said, `Employees are becoming more conscious of compliance with fair trade and the company's ethical management is strengthened"We will continue to promote continuous education and programs to expand this further in the future." he said.
This article was translated by Naver AI translator.
